Bahram Valamehr is CEO & President at FATE THERAPEUTICS INC (FATE). They have made 21 open-market trades across 1 company since 2019, most recently 2026-08-04.
CIK 0001748177
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FATE | 591,815 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FATE | SELL | 2026-08-04 | 2026-08-05 | $2.46 | $108K | -0.2% | -5.7% | -21.9% |
| FATE | SELL | 2026-05-20 | 2026-05-21 | $1.88 | $54K | +3.3% | +0.5% | +24.6% |
| FATE | SELL | 2026-01-09 | 2026-01-12 | $1.07 | $6K | +13.1% | +9.3% | +22.9% |
| FATE | SELL | 2025-08-04 | 2025-08-05 | $1.06 | $15K | +0.9% | -9.9% | +16.7% |
| FATE | SELL | 2025-01-10 | 2025-01-13 | $1.54 | $13K | +1.5% | -4.6% | -29.4% |
| FATE | SELL | 2024-01-09 | 2024-01-10 | $4.38 | $49K | +7.6% | +40.1% | +50.6% |
| FATE | SELL | 2023-01-10 | 2023-01-11 | $5.24 | $114K | -5.2% | +8.6% | -1.6% |
| FATE | SELL | 2022-07-07 | 2022-07-08 | $30.23 | $1.0M | +7.6% | +12.5% | -23.5% |
| FATE | SELL | 2022-07-06 | 2022-07-07 | $30.07 | $472K | +8.7% | +14.1% | -21.2% |
| FATE | SELL | 2022-03-14 | 2022-03-15 | $31.06 | $1.6M | +19.3% | +18.6% | -44.2% |
| FATE | SELL | 2022-01-11 | 2022-01-13 | $48.47 | $423K | -5.3% | -12.2% | -6.1% |
| FATE | SELL | 2022-01-10 | 2022-01-12 | $46.36 | $503K | -11.0% | -15.6% | -17.5% |
| FATE | SELL | 2021-12-13 | 2021-12-14 | $47.69 | $2.2M | +11.4% | -18.7% | -42.9% |
| FATE | SELL | 2021-09-13 | 2021-09-14 | $66.29 | $3.3M | +0.3% | -3.3% | -24.2% |
| FATE | SELL | 2021-06-14 | 2021-06-16 | $89.31 | $4.4M | +8.3% | -4.5% | -21.2% |
| FATE | SELL | 2021-03-15 | 2021-03-16 | $92.35 | $4.6M | -17.0% | -2.9% | +3.5% |
| FATE | SELL | 2021-01-08 | 2021-01-12 | $114.95 | $2.2M | -15.1% | -9.5% | -33.8% |
| FATE | SELL | 2020-12-14 | 2020-12-15 | $97.74 | $4.8M | +3.3% | +26.1% | -0.4% |
| FATE | SELL | 2020-09-14 | 2020-09-16 | $36.29 | $1.8M | +12.2% | +34.7% | +157.0% |
| FATE | SELL | 2020-01-08 | 2020-01-10 | $20.69 | $236K | +13.5% | +22.1% | +24.4% |
| FATE | SELL | 2019-10-15 | 2019-10-16 | $14.18 | $88K | +5.4% | +1.0% | +66.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.